Evidence map›Paper›PMID 42423833›Full record

ArticleGenetica2026

Molecular cytogenetic analysis in Pseudorasbora parva (Cypriniformes: Gobionidae)-important invasive fish species in Türkiye.

Atilla Arslan, Emine Arslan, Büşra Özçay Ekşi, Zafer Alpaslan, Alexandr Sember

Abstract read
PubMed Publisher
In one paragraph

Article in Genetica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Atilla ArslanDepartment of Biology, Faculty of Science, Selçuk University, Konya, Türkiye. aarslan@selcuk.edu.tr.ORCID http://orcid.org/0000-0002-4766-4969
Emine ArslanDepartment of Biology, Faculty of Science, Selçuk University, Konya, Türkiye.ORCID http://orcid.org/0000-0002-0782-506X
Büşra Özçay EkşiDepartment of Biology, Faculty of Science, Selçuk University, Konya, Türkiye.ORCID http://orcid.org/0000-0001-5458-939X
Zafer AlpaslanGraduate School of Natural Applied Sciences, Selçuk University, Konya, Türkiye.ORCID http://orcid.org/0000-0003-4555-0447
Alexandr SemberLaboratory of Fish Genetics, Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Rumburská 89, 277-21, Liběchov, Czech Republic.ORCID http://orcid.org/0000-0003-4441-9615

Funding

Selçuk University Scientific Research Projects Coordination Office 25401080
6 · The paper itself

Abstract

Topmouth gudgeon Pseudorasbora parva is a small invasive cyprinid fish widely distributed across Eurasia, including Türkiye. Although extensive, the available cytogenetic data from Asian populations is confined to standard karyotyping. Here we present the first molecular cytogenetic characterization of P. parva by analyzing the population from the Sakarya spring (Eskişehir Province, Türkiye). The aim was to examine the chromosomal organization and distribution of selected repetitive DNA sequences and this way to provide novel insights into karyotype evolution within Gobionidae and evaluate the utility of cytogenetic markers for freshwater management of this invasive species. To that end, we combined conventional karyotyping, C-banding, fluorescent and silver-nitrate staining with fluorescence in situ hybridization (FISH) using probes for tandemly repeated genes for ribosomal RNA (18S and 5S rDNA), small nuclear RNA (U1 and U2 snDNA), and telomeric (TTAGGG)

Indexed as

CypriniformesIntroduced SpeciesAnimalsCytogenetic AnalysisIn Situ Hybridization, FluorescenceKaryotypeKaryotyping5S and 18S rDNABiological invasionCytogenetic markerFluorescence in situ hybridizationPseudorasbora parvaTopmouth gudgeonU1 and U2 snDNA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.